BREANNA RANDOLPH: Open Payments
NPI 1336568690 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 40 payments from 10 companies in 2025. Trend: 2023 $903 · 2024 $851 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $489 |
| PFIZER INC. | 5 | $146 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: BOTOX, UBRELVY, NURTEC ODT, QULIPTA, Symbravo, Xeomin, RELISTOR, JOURNAVX.
Industry payments across TX — which companies pay providers there.
